News - Page 18 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article What Does FDA Expect from Lykos’ Next Phase 3 MDMA Study? (Part 1)

What Does FDA Expect from Lykos’ Next Phase 3 MDMA Study? (Part 1)

Post published:August 22, 2024
Post category:Analysis News Pα+

Read more about the article Natural Medicine Advisory Bulletin 13.5: The Birth of a Regulated Psychedelics Program

Natural Medicine Advisory Bulletin 13.5: The Birth of a Regulated Psychedelics Program

Post published:August 21, 2024
Post category:Colorado Natural Medicine Advisory Bulletin

Read more about the article Natural Medicine Advisory Bulletin 13: Peaking in July

Natural Medicine Advisory Bulletin 13: Peaking in July

Post published:August 20, 2024
Post category:Colorado Natural Medicine Advisory Bulletin

Read more about the article Breaking: Lykos Lays Off 75% of Staff, Ropes In Pharma Veteran, Doblin Resigns Board

Breaking: Lykos Lays Off 75% of Staff, Ropes In Pharma Veteran, Doblin Resigns Board

Post published:August 15, 2024
Post category:Analysis News Pα+

Read more about the article Pα+ Psychedelic Bulletin #170: Is MindMed Eyeing Depression? atai Approaches Phase 2 for DMT and R-MDMA Candidates; Compass’ Phase 3 Readout Timeline; European Psychiatrists Remain Open to Psychedelics

Pα+ Psychedelic Bulletin #170: Is MindMed Eyeing Depression? atai Approaches Phase 2 for DMT and R-MDMA Candidates; Compass’ Phase 3 Readout Timeline; European Psychiatrists Remain Open to Psychedelics

Post published:August 15, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Lykos Plots FDA Appeal: Reeling from CRL and Journal Article Retractions, MDMA Developer Hopes to Change Your Mind

Lykos Plots FDA Appeal: Reeling from CRL and Journal Article Retractions, MDMA Developer Hopes to Change Your Mind

Post published:August 13, 2024
Post category:Analysis News Pα+

Read more about the article BREAKING: FDA Rejects Lykos Therapeutics’ MDMA-Assisted Therapy For PTSD

BREAKING: FDA Rejects Lykos Therapeutics’ MDMA-Assisted Therapy For PTSD

Post published:August 9, 2024
Post category:Analysis News

Read more about the article Vibe Check: FDA Set to Decide Future of MDMA-Assisted Therapy This Week

Vibe Check: FDA Set to Decide Future of MDMA-Assisted Therapy This Week

Post published:August 6, 2024
Post category:Analysis News

Read more about the article Psychedelic Funding Update: Q2 2024

Psychedelic Funding Update: Q2 2024

Post published:August 1, 2024
Post category:Analysis Pα+

Read more about the article Pα+ Psychedelic Bulletin #169: Brin Backs Soneira, But Patent Questions Loom Large; J&J Seeks Spravato Monotherapy Approval; Canadian Study to Parse Out Role of Psychotherapy

Pα+ Psychedelic Bulletin #169: Brin Backs Soneira, But Patent Questions Loom Large; J&J Seeks Spravato Monotherapy Approval; Canadian Study to Parse Out Role of Psychotherapy

Post published:July 26, 2024
Post category:Psychedelic Bulletin Pα+

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.